Monday, April 13, 2020

Kadmon's (KDMN) ROCKstar - Will The Study Turn Out To Be True To Its Name?

The Company we are profiling today is also developing a drug for cGVHD - Kadmon Holdings Inc. (KDMN), and the drug candidate in focus is KD025.

from RTT - Biotech https://ift.tt/2V53ULM
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)